The Pharma Letter looks at whether semaglutide in pill form could stand in for weekly shots for people trying to lose weight.
Recap by typeshit. Full story at The Pharma Letter.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
A general drug reference post pointing to tirzepatide basics like interactions and warnings. Evergreen material with no new development behind it.
Investors wanted a near-term plan but got 2030 targets instead, while CagriSema missed against Zepbound and Morgan Stanley downgraded the stock over the semaglutide patent cliff.
Loading…